Eye movements in vertebrates are controlled by six extraocular muscles innervated by three of the cranial nerves -the oculomotor, trochlear and abducens. Incorrect development of this wiring network can lead to eye movement disorders, such as the congenital condition Duane retraction syndrome (DRS), which results in squint (strabismus). In DRS patients, the abducens nerve is often absent, and the oculomotor nerve branches to an inappropriate muscle target. How the program of neural projections to the extraocular muscles is regulated in normal or abnormal development is mostly unknown. However, our recent studies have identified mutations in the signalling molecule alpha2-chimaerin as being causal in DRS, and have shown that mutant forms of alpha2-chimaerin lead to striking axon guidance defects of the oculomotor nerve1. We are mapping axon projections to the extraocular muscles in normal development and Duane syndrome, using the zebrafish embryo as a model system. Timelapse movies of oculomotor axon guidance (using the Islet1-GFP line) show a stereotyped sequence of growth and branching to muscle targets, which differs from the pattern previously identified in the chick embryo. We are also using DNA injection or electroporation into oculomotor neurons and immunohistochemistry for nerve, muscle and/or synaptic components to precisely map the development of the ocular motor system. Fluorescently-tagged alpha2-chimaerin constructs harbouring known human mutations will then be expressed in oculomotor and/or abducens neurons in the zebrafish in order to determine how the axon projection pattern is disrupted, using a combination of live imaging and imaging of fixed embryos. In a collaborative effort with 30 other UK laboratories, we are characterising the expression and sub-cellular localisation of the YFP-tagged proteins and annotating the data using a web-interfaced database (FlAnnotator). We have examined 346 lines so far and characterised the localisation of the tagged proteins in the cellularising embryo (stage 5), as well as documenting expression levels and patterns during mid-(stage 11) and late-(stages 15-17) embryogenesis. We found that out of 242 tagged proteins expressed at cellularisation, 54% were enriched in the cytoplasm, 25% in nuclei and 17% at the cell membrane (4% did not show enrichment in any sub-cellular compartments). We also found that out of 335 lines expressed during embryogenesis, 55% had tissue or organ-specific expression patterns, a common one being expression in the nervous system (18%). We are currently characterising the lines further to identify those that show differential expression or localisation during parasegmental boundary formation.
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